title: Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
authors.affiliation: Department of Anesthesiology, Emory University School of Medicine and Division of Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, Georgia 30322, USA.
authors.forename: Kenichi A
authors.initials: KA
authors.lastname: Tanaka
authors.forename: Amr A
authors.initials: AA
authors.lastname: Waly
authors.forename: William A
authors.initials: WA
authors.lastname: Cooper
authors.forename: Jerrold H
authors.initials: JH
authors.lastname: Levy
mesh_terms: D000368:Aged; D016063:Blood Loss, Surgical; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006679:HIV Seropositivity; D019918:Heart Valve Prosthesis Implantation; D006470:Hemorrhage / Q000188:drug therapy*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D033221:Jehovah's Witnesses; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D006490:Hemostatics; D011994:Recombinant Proteins; D015942:Factor VIIa